Financial reports
ARS
2023 FY
Annual report to shareholders
23 Apr 24
10-K
2023 FY
Annual report
10 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
6 Apr 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
Current reports
8-K
Entry into a Material Definitive Agreement
2 Apr 24
8-K
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
1 Apr 24
8-K
Departure of Directors or Certain Officers
7 Feb 24
8-K
Other Events
18 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
13 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
11 Dec 23
8-K
Surrozen Provides Third Quarter 2023 Financial Results
8 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
13 Oct 23
8-K
Surrozen Provides Second Quarter 2023 Financial Results
9 Aug 23
8-K
Departure of Directors or Certain Officers
19 Jul 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
25 Apr 24
D
$193.02 mm in equity / options / securities to be acquired, sold $193.02 mm, 18 investors
19 Apr 24
S-3
Shelf registration
18 Apr 24
S-8
Registration of securities for employees
10 Apr 24
424B3
Prospectus supplement
7 Feb 24
424B3
Prospectus supplement
22 Jan 24
424B3
Prospectus supplement
13 Dec 23
424B3
Prospectus supplement
11 Dec 23
424B3
Prospectus supplement
8 Nov 23
424B3
Prospectus supplement
9 Aug 23
Proxies
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
DEFA14A
Additional proxy soliciting materials
24 Oct 23
DEF 14A
Definitive proxy
24 Oct 23
PRE 14A
Preliminary proxy
13 Oct 23
DEFA14A
Additional proxy soliciting materials
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFM14A
Proxy related to merger
15 Jul 21
Other
EFFECT
Notice of effectiveness
26 Apr 24
EFFECT
Notice of effectiveness
7 Apr 23
EFFECT
Notice of effectiveness
6 Apr 23
EFFECT
Notice of effectiveness
20 Dec 22
CORRESP
Correspondence with SEC
15 Dec 22
UPLOAD
Letter from SEC
15 Dec 22
EFFECT
Notice of effectiveness
6 Apr 22
CORRESP
Correspondence with SEC
1 Apr 22
UPLOAD
Letter from SEC
1 Apr 22
EFFECT
Notice of effectiveness
30 Mar 22
Ownership
4
Yang Li
26 Apr 24
4
Craig C Parker
26 Apr 24
4
Charles O Williams
26 Apr 24
SC 13G
Stonepine Capital Management, LLC
19 Apr 24
4/A
Change in insider ownership (amended)
17 Apr 24
4/A
Tim Kutzkey
17 Apr 24
SC 13D/A
COLUMN GROUP III GP, LP
17 Apr 24
SC 13G
RA CAPITAL MANAGEMENT, L.P.
15 Apr 24
SC 13D/A
COLUMN GROUP III GP, LP
8 Apr 24
4
Charles O Williams
8 Apr 24